Oncogenic mutation of KRAS and TP53, which are the main driver genes in pancreatic cancer, is responsible for the activation of multiple cellular processes, such as proliferation, transformation, invasion, and survival (Bournet et al., 2016; Buscail et al., 2020). This evidence concerns the gene KRAS and familial pancreatic carcinoma.